Related Experiment Video
Updated: Jun 4, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
Papillomavirus capsid proteins mutually impact structure
Horng-Shen Chen1, Michael J Conway, Neil D Christensen
1Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
Abstract:
We studied a panel of mutant viruses containing wild-type and chimeric capsid HPV16 and HPV18 proteins. The mutant capsid protein expression, genome amplification, and episomal maintenance were comparable with the wild-type virus. However, the chimeric viruses varied in their titers from wild-type. We show that the intertypical mutant chimeric capsid viruses, that L2 affects the structure of L1 and that L1 affects the structure of L2 in the virion. These effects were measured using a panel of conformation-dependent neutralizing L1 MAbs and an L2 capsid surface peptide derived neutralizing antibody. These data suggest that variation of one capsid gene not only affects its own structure and antigenicity, but also affects the structure and antigenicity of the other capsid protein. Implications of our data suggest that for the continued effectiveness of a vaccine, variation in both capsid proteins need to be considered and not just the protein the vaccine is directed against.
Insights
Mutant human papillomavirus (HPV) capsid proteins reveal that changes in one protein affect the other. This suggests vaccines must consider variations in both HPV L1 and L2 capsid proteins for sustained effectiveness.
Area of Science:
- Virology
- Vaccine development
- Structural biology
Background:
- Human papillomavirus (HPV) is a common virus with two major capsid proteins, L1 and L2.
- Current HPV vaccines primarily target the L1 protein.
- Understanding the structural and antigenic interplay between L1 and L2 is crucial for vaccine efficacy.
Purpose of the Study:
- To investigate the structural and antigenic effects of chimeric capsid proteins between HPV16 and HPV18.
- To determine how variations in one capsid protein influence the other within the virion.
- To assess the implications for HPV vaccine design and effectiveness.
Main Methods:
- Construction and analysis of mutant viruses with wild-type and chimeric HPV16/HPV18 capsid proteins.
- Assessment of capsid protein expression, genome amplification, and episomal maintenance.
- Titration of chimeric viruses and comparison with wild-type.
- Utilizing conformation-dependent neutralizing L1 monoclonal antibodies (MAbs) and an L2 capsid surface peptide antibody to probe structural changes.
Main Results:
- Mutant and chimeric capsid protein expression, genome amplification, and episomal maintenance were comparable to wild-type.
- Chimeric viruses exhibited variations in titers compared to wild-type viruses.
- Intertypical mutant chimeric capsid viruses demonstrated that L2 affects L1 structure and L1 affects L2 structure within the virion.
- Structural and antigenic changes in one capsid protein were observed to impact the other.
Conclusions:
- Variation in one HPV capsid gene significantly impacts the structure and antigenicity of the other capsid protein.
- The interplay between L1 and L2 capsid proteins is critical for virion integrity and antigenicity.
- For sustained vaccine effectiveness, future strategies should consider variations in both HPV L1 and L2 capsid proteins, not solely the targeted protein.
Related Concept Videos
Viral Structure
Size and Structure of Viral Genomes
Introduction to Virus
Inhibitors of Virion Maturation and Assembly
Leaky Scanning
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

